Annual ROA
-164.06%
-71.48%-77.21%
December 31, 2023
Summary
- As of February 10, 2025, SYRE annual return on assets is -164.06%, with the most recent change of -71.48% (-77.21%) on December 31, 2023.
- During the last 3 years, SYRE annual ROA has fallen by -97.97% (-148.24%).
- SYRE annual ROA is now -461.46% below its all-time high of -29.22%, reached on December 1, 2015.
Performance
SYRE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-50.97%
-0.46%-0.91%
September 30, 2024
Summary
- As of February 10, 2025, SYRE quarterly return on assets is -50.97%, with the most recent change of -0.46% (-0.91%) on September 30, 2024.
- Over the past year, SYRE quarterly ROA has increased by +154.07% (+75.14%).
- SYRE quarterly ROA is now -92.63% below its all-time high of -26.46%, reached on December 1, 2015.
Performance
SYRE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
SYRE ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -77.2% | +75.1% |
| 3 y3 years | -148.2% | +37.9% |
| 5 y5 years | -147.5% | +37.9% |
SYRE ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -238.6% | at low | -10.2% | +78.8% |
| 5 y | 5-year | -238.6% | at low | -24.1% | +78.8% |
| alltime | all time | -461.5% | +53.5% | -92.6% | +85.6% |
Spyre Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -50.97%(+0.9%) |
| Jun 2024 | - | -50.51%(-55.6%) |
| Mar 2024 | - | -113.80%(-29.0%) |
| Dec 2023 | -164.06%(+77.2%) | -160.35%(-21.8%) |
| Sep 2023 | - | -205.04%(-14.9%) |
| Jun 2023 | - | -241.03%(+151.0%) |
| Mar 2023 | - | -96.04%(+6.0%) |
| Dec 2022 | -92.58%(+91.0%) | - |
| Dec 2022 | - | -90.61%(+10.4%) |
| Sep 2022 | - | -82.09%(+8.0%) |
| Jun 2022 | - | -75.99%(+33.5%) |
| Mar 2022 | - | -56.91%(+23.0%) |
| Dec 2021 | -48.46%(-26.7%) | -46.26%(+2.9%) |
| Sep 2021 | - | -44.97%(+9.5%) |
| Jun 2021 | - | -41.08%(-26.6%) |
| Mar 2021 | - | -55.93%(-11.8%) |
| Dec 2020 | -66.09%(-32.0%) | -63.38%(-8.3%) |
| Sep 2020 | - | -69.09%(-10.6%) |
| Jun 2020 | - | -77.27%(-4.3%) |
| Mar 2020 | - | -80.77%(+4.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -97.26%(+46.7%) | -77.17%(+6.6%) |
| Sep 2019 | - | -72.36%(+10.8%) |
| Jun 2019 | - | -65.30%(-0.4%) |
| Mar 2019 | - | -65.59%(-1.0%) |
| Dec 2018 | -66.28%(+49.8%) | -66.27%(+17.1%) |
| Sep 2018 | - | -56.61%(+11.2%) |
| Jun 2018 | - | -50.91%(+3.1%) |
| Mar 2018 | - | -49.37%(+13.1%) |
| Dec 2017 | -44.24%(+7.8%) | -43.64%(+9.1%) |
| Sep 2017 | - | -39.99%(+12.1%) |
| Jun 2017 | - | -35.67%(-4.5%) |
| Mar 2017 | - | -37.35%(+0.1%) |
| Dec 2016 | -41.05%(+40.5%) | -37.33%(-1.8%) |
| Sep 2016 | - | -38.02%(+4.7%) |
| Jun 2016 | - | -36.32%(+10.0%) |
| Mar 2016 | - | -33.03%(+24.8%) |
| Dec 2015 | -29.22%(-91.7%) | -26.46%(-14.8%) |
| Sep 2015 | - | -31.07%(-6.8%) |
| Jun 2015 | - | -33.34%(-30.2%) |
| Mar 2015 | - | -47.78%(-86.5%) |
| Dec 2014 | -353.14% | -353.14% |
FAQ
- What is Spyre Therapeutics annual return on assets?
- What is the all time high annual ROA for Spyre Therapeutics?
- What is Spyre Therapeutics annual ROA year-on-year change?
- What is Spyre Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly ROA year-on-year change?
What is Spyre Therapeutics annual return on assets?
The current annual ROA of SYRE is -164.06%
What is the all time high annual ROA for Spyre Therapeutics?
Spyre Therapeutics all-time high annual return on assets is -29.22%
What is Spyre Therapeutics annual ROA year-on-year change?
Over the past year, SYRE annual return on assets has changed by -71.48% (-77.21%)
What is Spyre Therapeutics quarterly return on assets?
The current quarterly ROA of SYRE is -50.97%
What is the all time high quarterly ROA for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly return on assets is -26.46%
What is Spyre Therapeutics quarterly ROA year-on-year change?
Over the past year, SYRE quarterly return on assets has changed by +154.07% (+75.14%)